During the past decade, Hennepin Healthcare Research Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hennepin Healthcare Research Institute" #1 sponsor was "Hennepin Healthcare Research Institute" with 10 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Amylyx Pharmaceuticals Inc." with 1 trials sponsored, "Comprehensive Research Associates" with 1 trials sponsored and "Johns Hopkins University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hennepin Healthcare Research Institute" #1 collaborator was "University of Minnesota" with 3 trials as a collaborator, "Brown University" with 2 trials as a collaborator, "HealthPartners Institute" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "Siemens Healthineers" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hennepin Healthcare Research Institute" are "COVID-19" (3 trials), "Acute Coronary Syndrome" (2 trials), "Acute Myocardial Infarction" (2 trials), "Amyotrophic Lateral Sclerosis" (2 trials) and "Cognitive Decline" (2 trials). Many other conditions were trialed in "Hennepin Healthcare Research Institute" in a lesser frequency.

Most popular intervention types in "Hennepin Healthcare Research Institute" are "Drug" (9 trials), "Other" (6 trials), "Behavioral" (4 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Remdesivir" (3 trials), "Cardiac Troponin Testing" (2 trials), "AMX0035" (1 trials) and "Ask-Advise-Refer" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hennepin Healthcare Research Institute" are 18 trials for "All" genders.

Currently, there are 10 active trials in "Hennepin Healthcare Research Institute". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Hennepin Healthcare Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hennepin Healthcare Research Institute, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Hennepin Healthcare Research Institute has several departments that took part in Clinical trials: "Minnesota Heart Failure Network" - 5 trials